Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Mental Disorders”

Showing 20 of 0 results

Not applicableStudy completedNCT00825799
What this trial is testing

Serum Markers as a Bioassay for Unipolar Depression

Who this might be right for
Major Depression
Steward St. Elizabeth's Medical Center of Boston, Inc. 160
Post-approval studies (Phase 4)UnknownNCT00628914
What this trial is testing

Brain Mechanisms and Targeting Insomnia in Major Depression

Who this might be right for
Major Depressive DisorderInsomnia
University of California, Los Angeles 60
Testing effectiveness (Phase 2)Study completedNCT01880593
What this trial is testing

Ketamine Plus Lithium in Treatment-Resistant Depression

Who this might be right for
Depression
Icahn School of Medicine at Mount Sinai 34
Testing effectiveness (Phase 2)Looking for participantsNCT05860699
What this trial is testing

Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation : CBD-OH

Who this might be right for
Severe Alcohol Use Disorder (DSM 5)
Assistance Publique - Hôpitaux de Paris 210
Post-approval studies (Phase 4)Study completedNCT01185977
What this trial is testing

Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)

Who this might be right for
Major Depressive Disorder
University of California, Los Angeles 26
Large-scale testing (Phase 3)Study completedNCT02943577
What this trial is testing

Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)

Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 429
Not applicableStudy completedNCT02626403
What this trial is testing

Fronto-parietal tDCS in Severely Brain Injured Patients With Disorders of Consciousness

Who this might be right for
Vegetative StateMinimally Conscious StateDisorders of Consciousness
University of Liege 46
Testing effectiveness (Phase 2)Study completedNCT00125554
What this trial is testing

Metyrapone as Additive Treatment in Major Depression

Who this might be right for
Major Depressive Disorder
Universitätsklinikum Hamburg-Eppendorf 63
Not applicableStudy completedNCT05841030
What this trial is testing

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 545
Not applicableStudy completedNCT01691092
What this trial is testing

PET Imaging of mGLuR5 With Drug Challenge

Who this might be right for
Major Depressive DisorderPost-Traumatic Stress Disorder (PTSD)
Yale University 79
Large-scale testing (Phase 3)Study completedNCT04853407
What this trial is testing

Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
Luye Pharma Group Ltd. 558
Testing effectiveness (Phase 2)Ended earlyNCT01766336
What this trial is testing

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 296
Early research (Phase 1)Study completedNCT01373931
What this trial is testing

LY2216684 in Healthy Females

Who this might be right for
Depressive Disorder, Major
Eli Lilly and Company 20
Not applicableUnknownNCT02715128
What this trial is testing

Disorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal Cortex

Who this might be right for
Major Depressive DisorderSchizophrenia
Ludwig-Maximilians - University of Munich 30
Testing effectiveness (Phase 2)WithdrawnNCT05675800
What this trial is testing

Psilocybin for Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Washington University School of Medicine
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07287839
What this trial is testing

Parcel-guided rTMS for Major Depressive Disorder

Who this might be right for
Treatment Resistant Depression (TRD)
Soterix Medical 60
Not applicableStudy completedNCT00621465
What this trial is testing

Critical Time Intervention in the Transition From Hospital to Community in People With Severe Mental Illness

Who this might be right for
Psychotic Disorders
New York State Psychiatric Institute 150
Post-approval studies (Phase 4)Study completedNCT00000375
What this trial is testing

Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
National Institute of Mental Health (NIMH)
Testing effectiveness (Phase 2)Study completedNCT06057012
What this trial is testing

BRII-296 in Adults With Severe Postpartum Depression (PPD)

Who this might be right for
Severe Postpartum Depression
Brii Biosciences Limited 11
Not applicableStudy completedNCT01683019
What this trial is testing

Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression

Who this might be right for
Major Depressive Disorder (MDD)
Wave Neuroscience 52
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation